In this forum, we will share traditional medical insights with the innovative world of omnichannel strategies.
Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
The objective is to illustrate how determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process.
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches.
Digital Science held a roundtable discussion with Medical Affairs leaders in Madrid in May 2024 on the topic of scientific communications strategies assessment and their success measurements for multiple stakeholders.
This article addresses the metrics that Medical Affairs can use to measure how effectively they communicate on their strategic imperatives, with a specific focus on Share of Scientific Voice (SoSV).